Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative intravenous corticosteroid and beta blocker for prevention of atrial fibrillation after cardiac surgery
2018-001430-18Phase 4Completed
- Sponsor
- Kuopio University Hospital
- Start
- Jul 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hydrocortisone sodium succinate and metoprolol in Atrial fibrillation (AFib), sponsored by Kuopio University Hospital. Primary endpoint: Sinus rhythm maintenance for three days postoperatively. Started Jul 2019; status: completed.
02
Drugs
hydrocortisone sodium succinatemetoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2018-001430-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001430-18.